Most ordered 
Novatec Vial
Tirzepatide Vial 60mg
Tirzepatide is a dual-action GLP-1/GIP metabolic peptide studied for appetite signalling, glucose regulation, and body-composition research.
£229
£3.82/mg
- Tracked delivery — UK typically 2–3 working days, EU 3–7.
- 1 third-party lab report on file
- Card payment at checkout, verified by your bank.
Product data
- Brand
- Novatec
- Format
- Vial
- Strength
- 60mg
- Compound
- Tirzepatide
- SKU
- MYO-VIAL-TIR-60MG
Handling — Vial
- Lyophilised (freeze-dried) powder in a sealed vial.
- Reconstitution is done by the researcher; bacteriostatic water is listed separately.
- Store refrigerated at 2–8°C and protect from light, as printed on the vial.
Same compound
Tirzepatide, in its other forms.
The same compound in other formats and from other brands. Prices per milligram are for the lowest-priced strength in stock.
- Myotech Pen TIRZEPATIDE [MOUNJARO] 10mg · 30mg · 60mg from £79 £7.90/mg
-
Novatec Vial Tirzepatide Vial 30mg 30mg £139 £4.63/mg -
Novatec Vial Tirzepatide Vial 10mg 10mg £79 £7.90/mg -
Novatec Vial Tirzepatide Vial 20mg 20mg £109 £5.45/mg
About this product
Tirzepatide is a next-generation peptide studied for its dual-pathway activity across the GLP-1 and GIP metabolic signalling pathways associated with appetite and glucose regulation.
By targeting multiple metabolic mechanisms, it has become one of the most widely researched peptides for weight-management and metabolic-optimisation protocols.
Research focus
- Dual-agonist (GLP-1 / GIP) peptide
- Appetite-signalling research
- Glucose-regulation pathways
- Body-composition optimisation studies
Supplied by NOVATEC as a purity-tested, single-dose lyophilised vial. For research purposes only — not for human or veterinary use.
Third-party testing
Lab reports
Issued by Janoshik Analytical for the peptide in this product. Each opens on the lab's own verification page.
All reports on file →Related products
Most ordered Most ordered